Holen Sie sich die Stockscreener-App
1.74
9.37%
-0.18
Handel nachbörslich:
1.81
0.07
+4.02%
Schlusskurs vom Vortag:
$1.92
Offen:
$1.95
24-Stunden-Volumen:
2.16M
Relative Volume:
6.66
Marktkapitalisierung:
$62.55M
Einnahmen:
$210.70K
Nettoeinkommen (Verlust:
$-21.37M
KGV:
-1.5818
EPS:
-1.1
Netto-Cashflow:
$-21.10M
1W Leistung:
-7.45%
1M Leistung:
+18.37%
6M Leistung:
-10.31%
1J Leistung:
+67.31%
1-Tages-Spanne:
$1.55
$1.95
1-Wochen-Bereich:
$1.55
$2.0499
52-Wochen-Spanne:
$1.00
$3.19
Gain Therapeutics Inc Stock (GANX) Company Profile
Firmenname
Gain Therapeutics Inc
Sektor
Branche
Telefon
(301) 500-1556
Adresse
4800 HAMPDEN LANE, BETHESDA
Vergleichen Sie GANX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GANX
Gain Therapeutics Inc
|
1.74 | 68.66M | 210.70K | -21.37M | -21.10M | -1.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Gain Therapeutics Inc Stock (GANX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-12-06 | Eingeleitet | ROTH MKM | Buy |
| 2024-08-14 | Fortgesetzt | Oppenheimer | Outperform |
| 2021-04-12 | Eingeleitet | BTIG Research | Buy |
| 2021-04-12 | Eingeleitet | Oppenheimer | Outperform |
Gain Therapeutics Inc Aktie (GANX) Neueste Nachrichten
Ranking Gain Therapeutics Inc. among high performing stocks via toolsQuarterly Risk Review & Weekly Return Optimization Alerts - Newser
Forecasting Gain Therapeutics Inc. price range with options dataJuly 2025 Technicals & AI Powered Buy/Sell Recommendations - Newser
What indicators show strength in Gain Therapeutics Inc.Market Sentiment Review & Free Safe Capital Growth Stock Tips - Newser
What’s next for Gain Therapeutics Inc. stock priceTrade Entry Report & Accurate Technical Buy Alerts - Newser
Analyzing recovery setups for Gain Therapeutics Inc. investors2025 Performance Recap & Risk Controlled Daily Plans - Newser
Visualizing Gain Therapeutics Inc. stock with heatmaps2025 Volume Leaders & Technical Confirmation Trade Alerts - Newser
Price action breakdown for Gain Therapeutics Inc.IPO Watch & Community Driven Trade Alerts - Newser
Gain Therapeutics Inc. recovery potential after sell offWeekly Trade Report & Technical Confirmation Trade Alerts - Newser
Developing predictive dashboards with Gain Therapeutics Inc. data2025 Earnings Surprises & Low Drawdown Investment Strategies - Newser
Is a relief rally coming for Gain Therapeutics Inc. holdersMarket Performance Report & Free Real-Time Volume Trigger Notifications - Newser
Using Ichimoku Cloud for Gain Therapeutics Inc. technicalsDollar Strength & Free High Accuracy Swing Entry Alerts - Newser
Live market analysis of Gain Therapeutics Inc.2025 Geopolitical Influence & Consistent Profit Trade Alerts - Newser
How to use a screener to detect Gain Therapeutics Inc. breakoutsTrade Volume Report & Risk Controlled Daily Trade Plans - Newser
Is this a good reentry point in Gain Therapeutics Inc.July 2025 Sentiment & Long-Term Safe Investment Plans - Newser
Gain Therapeutics Inc. stock volume spike explainedTrade Risk Summary & Detailed Earnings Play Alerts - Newser
Real time alert setup for Gain Therapeutics Inc. performance2025 Biggest Moves & AI Powered Market Entry Strategies - Newser
Gain Therapeutics: Targeting Parkinson’s at the Cellular Level - The Globe and Mail
Gain Therapeutics: Advancing Science in the Fight Against Parkinson’s - The Globe and Mail
Is Gain Therapeutics Inc. stock showing strong momentum2025 Biggest Moves & Weekly Return Optimization Plans - khodrobank.com
What drives Gain Therapeutics Inc.’s stock pricePrice Action & Weekly Top Performers Watchlists - khodrobank.com
Is Gain Therapeutics Inc. benefiting from innovation trendsM&A Rumor & Daily Technical Stock Forecast Reports - khodrobank.com
Performance Recap: What drives Gain Therapeutics Inc.’s stock priceMarket Activity Summary & Safe Capital Growth Tips - khodrobank.com
Is now a turning point for Gain Therapeutics Inc.Market Risk Summary & Stepwise Trade Execution Plans - Newser
What data driven models say about Gain Therapeutics Inc.’s futureWall Street Watch & Verified Trade Idea Suggestions - Newser
Parkinson’s Disease Pipeline Analysis, 2025 by DelveInsight | Annovis Bio, Cerevel Therapeutics, Roche, Inhibikase Therapeutics, Inc, Gain Therapeutics, Neuronascent, ANEW MEDICAL, Longevity Biotech, - Barchart.com
Real time social sentiment graph for Atossa Therapeutics Inc.Weekly Gains Summary & Breakout Confirmation Trade Signals - Newser
How institutional ownership impacts Gain Therapeutics Inc. stockMarket Movement Recap & AI Driven Stock Price Forecasts - Newser
Can Gain Therapeutics Inc. reach resistance levels soon2025 Breakouts & Breakdowns & Fast Moving Market Watchlists - خودرو بانک
Will breakout in Gain Therapeutics Inc. lead to full recovery2025 Risk Factors & Accurate Intraday Trade Tips - Newser
What the charts say about Gain Therapeutics Inc. today2025 Market Sentiment & Breakout Confirmation Trade Signals - Newser
Is Gain Therapeutics Inc. showing signs of accumulationTrade Analysis Summary & Capital Efficiency Focused Strategies - Newser
Gain Therapeutics Inc.’s volatility index tracking explainedWeekly Risk Summary & Daily Profit Focused Screening - Newser
MACD Signals Flash Warning for Gain Therapeutics Inc. StockWeekly Stock Analysis & Scalable Portfolio Growth Ideas - beatles.ru
Visual trend scoring systems applied to Gain Therapeutics Inc.Fed Meeting & Growth Focused Stock Pick Reports - Newser
Leading vs lagging indicators on Actuate Therapeutics Inc. performanceGold Moves & Detailed Earnings Play Alerts - Newser
Does XORTX Therapeutics Inc. fit your quant trading modelMarket Weekly Review & Daily Entry Point Alerts - Newser
Key resistance and support levels for Gain Therapeutics Inc.2025 Biggest Moves & AI Powered Market Entry Strategies - Newser
Finanzdaten der Gain Therapeutics Inc-Aktie (GANX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):